$58.57
1.85% today
Nasdaq, Nov 26, 05:19 pm CET
ISIN
US76155X1000
Symbol
RVMD
Sector
Industry

Revolution Medicines Inc Target price 2024 - Analyst rating & recommendation

Revolution Medicines Inc Classifications & Recommendation:

Buy
100%

Revolution Medicines Inc Price Target

Target Price $71.92
Price $57.50
Potential
Number of Estimates 13
13 Analysts have issued a price target Revolution Medicines Inc 2025 . The average Revolution Medicines Inc target price is $71.92. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 14 analysts: 14 Analysts recommend Revolution Medicines Inc to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Revolution Medicines Inc stock has an average upside potential 2025 of . Most analysts recommend the Revolution Medicines Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 11.58 0.32
67.27% 97.22%
EBITDA Margin -4,126.77% -205,367.17%
487.26% 4,876.46%
Net Margin -5,591.67% -183,646.66%
282.90% 3,184.29%

14 Analysts have issued a sales forecast Revolution Medicines Inc 2024 . The average Revolution Medicines Inc sales estimate is

$321k
Unlock
. This is
56.57% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$4.5m 508.11%
Unlock
, the lowest is
$0.0 100.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $11.6m 67.27%
2024
$321k 97.22%
Unlock
2025
$6.3m 1,855.72%
Unlock
2026
$21.7m 245.99%
Unlock
2027
$178m 719.06%
Unlock
2028
$589m 230.88%
Unlock

4 Analysts have issued an Revolution Medicines Inc EBITDA forecast 2024. The average Revolution Medicines Inc EBITDA estimate is

$-660m
Unlock
. This is
2.84% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-638m 0.58%
Unlock
, the lowest is
$-677m 5.51%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-478m 92.21%
2024
$-660m 38.13%
Unlock
2025
$-735m 11.31%
Unlock
2026
$-805m 9.56%
Unlock
2027
$-877m 8.93%
Unlock
2028
$-486m 44.60%
Unlock

EBITDA Margin

2023 -4,126.77% 487.26%
2024
-205,367.17% 4,876.46%
Unlock
2025
-11,689.43% 94.31%
Unlock
2026
-3,701.66% 68.33%
Unlock
2027
-492.28% 86.70%
Unlock
2028
-82.43% 83.26%
Unlock

9 Revolution Medicines Inc Analysts have issued a net profit forecast 2024. The average Revolution Medicines Inc net profit estimate is

$-590m
Unlock
. This is
1.98% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-574m 4.73%
Unlock
, the lowest is
$-668m 10.86%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-648m 25.32%
2024
$-590m 8.84%
Unlock
2025
$-685m 16.07%
Unlock
2026
$-732m 6.91%
Unlock
2027
$-744m 1.54%
Unlock
2028
$-424m 42.94%
Unlock

Net Margin

2023 -5,591.67% 282.90%
2024
-183,646.66% 3,184.29%
Unlock
2025
-10,900.36% 94.06%
Unlock
2026
-3,368.14% 69.10%
Unlock
2027
-417.56% 87.60%
Unlock
2028
-72.01% 82.75%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -3.86 -3.52
25.32% 8.81%
P/E negative
EV/Sales 25,541.63

9 Analysts have issued a Revolution Medicines Inc forecast for earnings per share. The average Revolution Medicines Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-3.52
Unlock
. This is
1.95% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-3.42 4.74%
Unlock
, the lowest is
$-3.98 10.86%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-3.86 25.32%
2024
$-3.52 8.81%
Unlock
2025
$-4.08 15.91%
Unlock
2026
$-4.37 7.11%
Unlock
2027
$-4.43 1.37%
Unlock
2028
$-2.53 42.89%
Unlock

P/E ratio

Current -16.01 142.21%
2024
-16.34 2.06%
Unlock
2025
-14.08 13.83%
Unlock
2026
-13.17 6.46%
Unlock
2027
-12.97 1.52%
Unlock
2028
-22.73 75.25%
Unlock

Based on analysts' sales estimates for 2024, the Revolution Medicines Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

25,541.63
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
30,092.46
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 11,094.35 17,886.95%
2024
25,541.63 130.22%
Unlock
2025
1,306.11 94.89%
Unlock
2026
377.50 71.10%
Unlock
2027
46.09 87.79%
Unlock
2028
13.93 69.78%
Unlock

P/S ratio

Current 13,071.07 14,367.45%
2024
30,092.46 130.22%
Unlock
2025
1,538.82 94.89%
Unlock
2026
444.77 71.10%
Unlock
2027
54.30 87.79%
Unlock
2028
16.41 69.78%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today